UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

High circulating D-dimers are associated with ascites and hepatocellular carcinoma in liver cirrhosis

World journal of gastroenterology : WJG, 2008-03, Vol.14 (10), p.1549-1552

2008

Volltextzugriff (PDF)

Serum chromogranin-A in hepatocellular carcinoma: diagnostic utility and limits

World journal of gastroenterology : WJG, 2005-04, Vol.11 (13), p.1987

2005

Volltextzugriff (PDF)

Effect of Potassium Canrenoate, an Anti-aldosterone Agent, on Incidence of Ascites and Variceal Progression in Cirrhosis

Clinical gastroenterology and hepatology, 2006-11, Vol.4 (11), p.1395-1402

2006

Volltextzugriff (PDF)

Low utility of plasma Nociceptin/orphanin FQ in the diagnosis of hepatocellular carcinoma

World journal of gastroenterology : WJG, 2006-08, Vol.12 (29), p.4716

2006

Volltextzugriff (PDF)

Soluble CD30 serum levels before and after treatment with α-interferon in patients with chronic hepatitis C

Clinical chemistry and laboratory medicine, 2005, Vol.43 (8), p.823-826

2005

Volltextzugriff (PDF)

Serum thrombopoietin in chronic liver disease: relation to severity of the disease and spleen size

Hepato-gastroenterology, 2002-09, Vol.49 (47), p.1382

2002

Volltextzugriff (PDF)

Risk of inflammatory bowel disease attributable to smoking, oral contraception and breastfeeding in Italy: a nationwide case-control study

International journal of epidemiology, 1998-06, Vol.27 (3), p.397-404

1998

Volltextzugriff (PDF)

Efficacy of interferon treatment (IFN) in elderly patients with chronic hepatitis C

Le infezioni in medicina, 2003-12, Vol.11 (4), p.208

2003

Volltextzugriff (PDF)

Prospective validation of the CLIP score: A new prognostic system for patients with cirrhosis and hepatocellular carcinoma

Hepatology (Baltimore, Md.), 2000-04, Vol.31 (4), p.840-845

2000

Volltextzugriff (PDF)

Focal lymphocytic aggregates in chronic hepatitis C: Occurrence, immunohistochemical characterization, and relation to markers of autoimmunity

Hepatology (Baltimore, Md.), 1995, Vol.22 (2), p.389-394

1995

Volltextzugriff (PDF)

Focal lymphocytic aggregates in chronic hepatitis C: Occurrence, immunohistochemical characterization, and relation to markers of autoimmunity

Hepatology (Baltimore, Md.), 1995-08, Vol.22 (2), p.389-394

1995

Volltextzugriff (PDF)

Topical treatment of distal active ulcerative colitis with beclomethasone dipropionate or mesalamine: a single-blind randomized controlled trial

Journal of clinical gastroenterology, 2005-04, Vol.39 (4), p.291-297

2005

Volltextzugriff (PDF)

Class I HLA antigens hepatic display and beta-2-microglobulin serum values in chronic hepatitis C: effect of treatment with recombinant alpha interferon

Hepato-gastroenterology, 1997-09, Vol.44 (17), p.1295

1997

Volltextzugriff (PDF)

Soluble CD30 serum levels before and after treatment with I--interferon in patients with chronic hepatitis C

Clinical chemistry and laboratory medicine, 2005-08, Vol.43 (8), p.823-826

2005

Volltextzugriff (PDF)

Interferon retreatment of patients with chronic hepatitis C. A long-term follow-up

Hepato-gastroenterology, 1999-11, Vol.46 (30), p.3229

1999

Volltextzugriff (PDF)

Ten year follow-up of patients with chronic hepatitis C treated with interferon

Hepato-gastroenterology, 1999-07, Vol.46 (28), p.2447

1999

Volltextzugriff (PDF)

Chemotherapy for Elderly Patients With Advanced Non-Small-Cell Lung Cancer: The Multicenter Italian Lung Cancer in the Elderly Study (MILES) Phase III Randomized Trial

JNCI : Journal of the National Cancer Institute, 2003-03, Vol.95 (5), p.362-372

2003

Volltextzugriff (PDF)

Advanced non-small cell lung cancer management in patients progressing after first-line treatment: results of the cross-sectional phase of the Italian LIFE observational study

Journal of cancer research and clinical oncology, 2014-10, Vol.140 (10), p.1783-1793

2014

Volltextzugriff (PDF)

Management of Italian Patients With Advanced Non–Small-Cell Lung Cancer After Second-Line Treatment: Results of the Longitudinal Phase of the LIFE Observational Study

Clinical lung cancer, 2014-09, Vol.15 (5), p.338-345.e1

2014

Volltextzugriff (PDF)

The impact of anemia on quality of life and hospitalisation in elderly cancer patients undergoing chemotherapy

Critical reviews in oncology/hematology, 2011-01, Vol.77 (1), p.70-77

2011

Volltextzugriff (PDF)

A multicenter, randomized, Phase II study of cisplatin, etoposide, and gemcitabine or cisplatin plus gemcitabine as first‐line treatment in patients with poor‐prognosis small cell lung carcinoma

Cancer, 2005-02, Vol.103 (4), p.772-779

2005

Volltextzugriff (PDF)

O-279 A multicenter randomised phase II study of cisplatin, etoposide, gemcitabine (PEG) versus cisplatin, gemcitabine (PG) as first line treatment in patients with small cell lung cancer (SCLC): Preliminary results

Lung cancer (Amsterdam, Netherlands), 2003-08, Vol.41, p.S81-S82

2003

Volltextzugriff (PDF)

1 – 23 von 23

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(20)
Mit Volltextzugriff
(16)

Publikationsform

Artikel
(23)

Sprache

Englisch
(23)

Erscheinungsjahr

n.n

Thema

Female
(18)
Humans
(18)
Life Sciences & Biomedicine
(18)
Male
(18)
Science & Technology
(18)
Middle Aged
(16)
Aged
(15)
Adult
(11)
Gastroenterology & Hepatology
(11)
Biological And Medical Sciences
(10)
Medical Sciences
(10)
Aged, 80 And Over
(7)
Treatment Outcome
(7)
Oncology
(6)
Chronic Hepatitis C
(5)
Chemotherapy
(4)
Disease Progression
(4)
Gastroenterology. Liver. Pancreas. Abdomen
(4)
Lung Neoplasms - Drug Therapy
(4)
Recombinant Proteins
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

High circulating D-dimers are associated with ascites and hepatocellular carcinoma in liver cirrhosis

Serum chromogranin-A in hepatocellular carcinoma: diagnostic utility and limits

Effect of Potassium Canrenoate, an Anti-aldosterone Agent, on Incidence of Ascites and Variceal Progression in Cirrhosis

Low utility of plasma Nociceptin/orphanin FQ in the diagnosis of hepatocellular carcinoma

Soluble CD30 serum levels before and after treatment with α-interferon in patients with chronic hepatitis C

Serum thrombopoietin in chronic liver disease: relation to severity of the disease and spleen size

Risk of inflammatory bowel disease attributable to smoking, oral contraception and breastfeeding in Italy: a nationwide case-control study

Efficacy of interferon treatment (IFN) in elderly patients with chronic hepatitis C

Prospective validation of the CLIP score: A new prognostic system for patients with cirrhosis and hepatocellular carcinoma

Focal lymphocytic aggregates in chronic hepatitis C: Occurrence, immunohistochemical characterization, and relation to markers of autoimmunity

Focal lymphocytic aggregates in chronic hepatitis C: Occurrence, immunohistochemical characterization, and relation to markers of autoimmunity

Topical treatment of distal active ulcerative colitis with beclomethasone dipropionate or mesalamine: a single-blind randomized controlled trial

Class I HLA antigens hepatic display and beta-2-microglobulin serum values in chronic hepatitis C: effect of treatment with recombinant alpha interferon

Soluble CD30 serum levels before and after treatment with I--interferon in patients with chronic hepatitis C

Interferon retreatment of patients with chronic hepatitis C. A long-term follow-up

Ten year follow-up of patients with chronic hepatitis C treated with interferon

Chemotherapy for Elderly Patients With Advanced Non-Small-Cell Lung Cancer: The Multicenter Italian Lung Cancer in the Elderly Study (MILES) Phase III Randomized Trial

Afatinib versus methotrexate as second-line treatment in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck progressing on or after platinum-based therapy (LUX-Head & Neck 1): an open-label, randomised phase 3 trial

Advanced non-small cell lung cancer management in patients progressing after first-line treatment: results of the cross-sectional phase of the Italian LIFE observational study

Management of Italian Patients With Advanced Non–Small-Cell Lung Cancer After Second-Line Treatment: Results of the Longitudinal Phase of the LIFE Observational Study

The impact of anemia on quality of life and hospitalisation in elderly cancer patients undergoing chemotherapy

A multicenter, randomized, Phase II study of cisplatin, etoposide, and gemcitabine or cisplatin plus gemcitabine as first‐line treatment in patients with poor‐prognosis small cell lung carcinoma

O-279 A multicenter randomised phase II study of cisplatin, etoposide, gemcitabine (PEG) versus cisplatin, gemcitabine (PG) as first line treatment in patients with small cell lung cancer (SCLC): Preliminary results

Suchergebnisse filtern